Large-Bore Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism in Patients with Contraindications to Thrombolytics | Outcomes from the Non-Randomized PEERLESS Cohort

Tuesday, March 11, 2025

8:20 AM – 8:30 AM ET

Speaker(s)

Stefan Stortecky, MD, MPH

Senior Consultant Interventional Cardiology
Swiss Cardiovascular Center Bern
Bern, Bern, Switzerland

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); Inari Medical: Consultant (Ongoing); Medtronic, Inc.: Grant/Research Support (Ongoing)

Disclosure(s):

Stefan Stortecky, MD, MPH: Abbott Vascular: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); Inari Medical: Consultant (Ongoing); Medtronic, Inc.: Grant/Research Support (Ongoing)